Drug General Information
Drug ID
D0H9SX
Former ID
DIB014929
Drug Name
Daporinad
Synonyms
APO-866; FK-866; WK-175
Drug Type
Small molecular drug
Indication Leukemia [ICD9: 208.9; ICD10:C90-C95] Phase 2 [529259], [542710]
Company
Astellas Pharma GmbH
Structure
Download
2D MOL

3D MOL

Formula
C24H29N3O2
InChI
InChI=1S/C24H29N3O2/c28-23(12-11-21-8-6-15-25-19-21)26-16-5-4-7-20-13-17-27(18-14-20)24(29)22-9-2-1-3-10-22/h1-3,6,8-12,15,19-20H,4-5,7,13-14,16-18H2,(H,26,28)/b12-11+
InChIKey
KPBNHDGDUADAGP-VAWYXSNFSA-N
CAS Number
CAS 201034-75-5
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Nicotinamide phosphoribosyltransferase Target Info Inhibitor [529259]
BioCyc Pathway NAD salvage
KEGG Pathway Nicotinate and nicotinamide metabolism
Metabolic pathways
NetPath Pathway IL2 Signaling Pathway
IL1 Signaling Pathway
TCR Signaling Pathway
PathWhiz Pathway Nicotinate and Nicotinamide Metabolism
Reactome BMAL1:CLOCK,NPAS2 activates circadian gene expression
WikiPathways Adipogenesis
Metabolism of water-soluble vitamins and cofactors
Circadian Clock
References
Ref 529259Anticancer agent CHS-828 inhibits cellular synthesis of NAD. Biochem Biophys Res Commun. 2008 Mar 21;367(4):799-804.
Ref 542710(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7745).
Ref 529259Anticancer agent CHS-828 inhibits cellular synthesis of NAD. Biochem Biophys Res Commun. 2008 Mar 21;367(4):799-804.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.